Migraine-like Headache in a Patient with Complement 1 Inhibitor Deficient Hereditary Angioedema

다국어 초록 (Multilingual Abstract)

We report on an angioedema patient with a genetic defect in complement 1 inhibitor,manifesting migraine-like episodes of headache, effective prophylaxis with Danazol, and triptan for a treatment of acute clinical episode. The patient was 44-yr-old Korean man with abdominal pain and headache, who was brought into the Emergency Department of Seoul National University Hospital, Seoul. He suffered from frequent attacks of migrainelike headache (3-7 per month), pulsating in nature associated with nausea. Severities were aggravated by activity and his headache had shown recent progression with abdominal pain. No remarkable findings were observed on radiologic examination, brain magnetic resonance images and intracranial and extracranial magnetic resonance angiography.
Danazol 200 mg every other day was subsequently used. Following administration of Danazol, symptoms showed improvement and the patient was discharged. While taking Danazol, the migraine-like episodes appeared to be prevented for about 2 yr. At the eighth month, he suffered a moderate degree of migraine-like headache; however, administration of naratriptan 2.5 mg resolved his problem. A case of genetic defect of C1-INH deficiency presented with headache episodes, and was controlled by Danazol and triptan. It suggests that pathogenic mechanism of headache in hereditary angioedema may be mediated by the neurogenic inflammatory-like physiology of migraine.

참고문헌 (Reference)

1 Johnston MM, "Triptans for the management of migraine" 70 : 1505-1518, 2010

2 Gelfand JA, "Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities" 295 : 1444-1448, 1976

3 Markowitz S, "Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain" 7 : 4129-4136, 1987

4 Tepper SJ, "Mechanisms of action of the 5-HT1B/1D receptor agonists" 59 : 1084-1088, 2002

5 Pappalardo E, "Mechanisms of C1-inhibitor deficiency" 205 : 542-551, 2002

6 Welch KM, "MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine" 51 : 1465-1469, 1998

7 Bork K, "Hereditary angioedema: new findings concerning symptoms, affected organs, and course" 119 : 267-274, 2006

8 Luong KV, "Headache and complement C’1-esterase inhibitor deficiency in Vietnamese immigrants living in southern California" 20 : 127-133, 1999

9 Goodman LS, "Goodman & Gilman’s manual of pharmacology and therapeutics" McGraw-Hill Medical 2008

10 한설희, "Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial" 대한신경과학회 6 (6): 27-32, 2010

11 강은호, "Effect of Biofeedback-assisted Autogenic Training on Headache Activity and Mood States in Korean Female Migraine Patients" 대한의학회 24 (24): 936-940, 2009

12 Buzzi MG, "Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion" 30 : 1193-1200, 1991

13 Agostoni A, "Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema" 65 : 75-79, 1980

14 Limmroth V, "Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine" 138 : 60-65, 1996

15 Woods RP, "Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache" 331 : 1689-1692, 1994